Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 450 participants.
Also called NCT02527811
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 450 participants
- Sponsor
- Techpool Bio-Pharma Co., Ltd.
- Registry
-
NCT02527811
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02527811. Randomized; single masking; primary purpose treatment. Start 2015-04 (registry gives no type); primary completion 2018-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery
- Condition
- Congenital Heart Diseases
- Intervention (Drug)
- Ulinastatin
- Lead sponsor
- Techpool Bio-Pharma Co., Ltd.
- Collaborator
- Shanghai Children's Medical Center
- Collaborator
- Guangzhou Women and Children's Medical Center
- Collaborator
- Guangzhou General Hospital of Guangzhou Military Command
- Collaborator
- Nanjing Children's Hospital
- Collaborator
- Children's Hospital of Fudan University
Record details
- Record id
cardio:ct-nct02527811- Content hash
119d3e6f132881902ba02783fe69cdfa3999db488b741d37fe0f27d759426451